British drug maker AstraZeneca rejected Monday what its New York-based rival Pfizer called over the weekend its "final" takeover offer.
AstraZeneca rejects Pfizer's 'final' $116B bid
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.